JW Holdings Corporation (KRX:096760)
South Korea
· Delayed Price · Currency is KRW 3,000.00
+15.00 (0.50%)
At close: Apr 16, 2025, 3:30 PM KST
JW Holdings Revenue
In the year 2024, JW Holdings had annual revenue of 887.71B KRW, down -4.35%. JW Holdings had revenue of 223.51B in the quarter ending December 31, 2024, a decrease of -14.54%.
Revenue
887.71B
Revenue Growth
-4.35%
P/S Ratio
0.24
Revenue / Employee
6.53B
Employees
136
Market Cap
212.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 887.71B | -40.36B | -4.35% |
| Dec 31, 2023 | 928.07B | 63.54B | 7.35% |
| Dec 31, 2022 | 864.54B | 75.60B | 9.58% |
| Dec 31, 2021 | 788.94B | 7.42B | 0.95% |
| Dec 31, 2020 | 781.51B | 53.43B | 7.34% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 68.13B |
| LigaChem Biosciences | 125.90B |
| PharmaResearch | 350.12B |